Prevalence of infectious agents in patients with systemic sclerosis: defining the control group Reply

Basit Öğe Kaydı
dc.contributor.authorBilgin, Huseyin
dc.contributor.authorKocabas, Hilal
dc.contributor.authorKesli, Recep
dc.date.accessioned2025-10-24T18:10:26Z
dc.date.available2025-10-24T18:10:26Z
dc.date.issued2016
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.endpage1612
dc.identifier.issn1300-0144
dc.identifier.issn1303-6165
dc.identifier.issue5
dc.identifier.startpage1612
dc.identifier.urihttps://hdl.handle.net/20.500.12899/4174
dc.identifier.volume46
dc.identifier.wosWOS:000389053000049
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherTubitak Scientific & Technological Research Council Turkey
dc.relation.ispartofTurkish Journal Of Medical Sciences
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20251023
dc.subjectHelicobacter-Pylori Infection; Stool Antigen Tests; Diagnosis
dc.titlePrevalence of infectious agents in patients with systemic sclerosis: defining the control group Reply
dc.typeLetter

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu